One-glance verdict
Within fair range
$123.63 our estimate vs market $127.17
Wall Street consensus: $162.25 (31.2% higher than our fair-value estimate)
3% above our estimate
Fundamentals snapshot
AptarGroup, Inc.
ATR · NYQ · Healthcare · Medical Instruments & Supplies
Current price
$127.17
52-week range
$103.23 - $146.91
Market cap
$8.09B
Balance sheet
Watch
9.69x Adequate
Net debt $1.21B. Interest coverage shows how many times profit covers the interest bill.
What stands out
3 Rewards
1 Risk
3 rewards · 1 risks
- Reward Revenue grew 4.1% last year.
- Reward Returns 13.5% on equity, ahead of 60% of its peers.
- Reward Free cash flow was positive in 10/10 years.
- Risk Net debt grew 4.2% over 3 years.
What this company does
AptarGroup, Inc.
AptarGroup makes dispensing pumps and closures for things like lotions, perfumes, and medicines, with most of their sales coming from these everyday product packaging items. This matters because their ability to consistently deliver these essential components to various industries like beauty and pharmaceuticals helps them maintain steady income.
How the company got here
AptarGroup, Inc. was incorporated in 1992, building on a legacy of innovation in dispensing technologies. The company has grown by strategically acquiring businesses and expanding its product offerings to serve a wide range of consumer and healthcare markets. This expansion has allowed Aptar to become a global leader in specialized dispensing and packaging solutions, adapting to evolving consumer needs and regulatory landscapes.
What it actually does
AptarGroup designs and manufactures a variety of dispensing systems and packaging solutions. Think of the pumps on your lotion bottles, the spray mechanisms on your perfume, or the specialized closures on medicine containers – Aptar likely makes them. They also create active material science solutions that help protect products and digital health tools to improve how people manage their health. Their products are found in everyday items across the pharmaceutical, beauty, personal care, home care, and food and beverage industries.
Pharma
The Pharma segment is a significant part of Aptar's business, focusing on dispensing solutions for the healthcare industry. This includes nasal spray pumps for medications, metered-dose valves for inhalers, and specialized components for injectable drugs. These products are crucial for delivering medications accurately and safely, and they are sold to pharmaceutical companies that develop and market these treatments. This segment is vital for Aptar, contributing a substantial portion of its overall revenue.
Beauty
Aptar's Beauty segment provides innovative dispensing solutions for the fragrance, skincare, and color cosmetics markets. This includes elegant pumps for perfumes, fine-mist sprayers for facial mists, and sophisticated dispensing systems for lotions and creams. These products are designed to enhance the user experience and brand appeal for beauty products, and they are sold to major cosmetic and fragrance companies. This segment represents another key area of Aptar's operations, driving a considerable share of its sales.
Closures
The Closures segment offers a broad range of dispensing and non-dispensing closures for various consumer end markets, including food and beverage, home care, and personal care. These are the caps and lids on many everyday products, designed for convenience and product integrity. For example, they make dispensing closures that allow you to pour or spray without removing the cap entirely. This segment is a foundational part of Aptar's business, contributing a notable portion of its revenue through a wide variety of packaging solutions.
What management is betting on now
Aptar's management is focused on expanding its leadership in innovative dispensing solutions, particularly within the growing pharmaceutical and beauty markets. They are investing in advanced technologies, such as digital health solutions that integrate with their dispensing devices, to offer more value to customers. The company is also prioritizing sustainability in its product development and manufacturing processes, aiming to reduce environmental impact. These strategic priorities are designed to drive future growth and maintain Aptar's competitive edge in its key markets.
Price history
How the share price has moved
—
Loading price history…
Earnings history
Last 8 quarters — what happened
Click any quarter to read the call summary and what the numbers say.
FY2024 Q3
$162.71M
FY2024 Q4
$112.17M
FY2025 Q1
$25.88M
FY2025 Q2
$62.53M
FY2025 Q3
$114.29M
FY2025 Q4
$96.87M
FY2026 Q1
$53.30M
FY2026 Q2
$45.92M
Revenue
$1.03B
Net income
$87.57M
Diluted EPS
1.36
Operating cash flow
$103.49M
Free cash flow
$45.92M
Fetching…
Sources
Revenue
$982.87M
Net income
$72.67M
Diluted EPS
1.12
Operating cash flow
$118.69M
Free cash flow
$53.30M
Fetching…
Sources
Revenue
$962.74M
Net income
$74.34M
Diluted EPS
1.13
Operating cash flow
$183.69M
Free cash flow
$96.87M
Fetching…
Sources
Revenue
$961.13M
Net income
$127.93M
Diluted EPS
1.92
Operating cash flow
$177.61M
Free cash flow
$114.29M
Fetching…
Sources
Revenue
$966.01M
Net income
$111.72M
Diluted EPS
1.67
Operating cash flow
$125.96M
Free cash flow
$62.53M
Fetching…
Sources
Revenue
$887.30M
Net income
$78.80M
Diluted EPS
1.17
Operating cash flow
$82.74M
Free cash flow
$25.88M
Fetching…
Sources
Revenue
$848.09M
Net income
$100.94M
Diluted EPS
1.48
Operating cash flow
$178.24M
Free cash flow
$112.17M
Fetching…
Sources
Revenue
$909.29M
Net income
$100.04M
Diluted EPS
1.48
Operating cash flow
$229.26M
Free cash flow
$162.71M
Fetching…
Sources
Is it cheap or expensive?
Fair value $123.63 vs current price $127.17
Wall Street consensus is the average analyst price target: $162.25 (31.2% higher than our fair-value estimate).
Our most-likely fair value is $123.63 a share — about 2.8% away from today's price of $127.17, so the stock currently looks fairly priced.
Is it drowning in debt?
Watch
Net debt $1.2B. Interest coverage 9.7x.
Net debt
$1.21B
Interest coverage
9.69x
AptarGroup, Inc.'s profit covers its interest bill about 9.7 times over. which is stronger than most peers shown here.
Watch
Worse cushion
Baseline
Better cushion
ATR
BASELINE
AptarGroup, Inc.
Total debt $1.41B Interest coverage 9.69x This is the baseline the peer rows are being compared against.
Total debt $316.50M Interest coverage 1,272.20x +13,033% vs ATR Carries about 131.3x more debt cushion than ATR.
Total debt $15.14B Interest coverage 3.25x -66% vs ATR Carries about 3.0x less debt cushion than ATR.
Total debt $4.83B Interest coverage 3.48x -64% vs ATR Carries about 2.8x less debt cushion than ATR.
Total debt $16.81B Interest coverage 4.87x -50% vs ATR Carries about 2.0x less debt cushion than ATR.
What you should know
The case for and against ATR
3 Rewards
1 Risk
Rewards
-
Revenue grew 4.1% last year.
-
Returns 13.5% on equity, ahead of 60% of its peers.
-
Free cash flow was positive in 10/10 years.
Risks
-
Net debt grew 4.2% over 3 years.
The numbers
All the key metrics, grouped by purpose
Tap any ? icon to learn what it means.
Valuation
How expensive the stock looks
P/E (TTM)
22.95x
Forward P/E
20.59x
P/B
3.08x
P/S
2.06x
EV/EBITDA
11.71x
PEG ratio
2.82x
Profitability
How much profit each dollar creates
Gross margin
36.1%
Operating margin
12.5%
Net margin
9.2%
ROE
13.5%
ROA
6.1%
Health
Liquidity and balance-sheet strength
Debt / equity
0.53x
Current ratio
1.61x
Quick ratio
0.98x
Total debt
$1.41B
Total cash
$197.27M
Growth
How the business has been compounding
Revenue TTM
$3.93B
Revenue 5Y CAGR
4.0%
EPS TTM
5.54
EPS 5Y CAGR
17.9%
Cash flow
How much cash the business throws off
Operating CF TTM
$583.48M
Free CF TTM
$299.58M
FCF margin
7.6%
Dividend
Shareholder payout
Yield
1.5%
Payout ratio
34.1%
Last ex-div date
2026-07-30